Company Filing History:
Years Active: 2024
Title: **Cristhina Kellen Fae: Innovator in Immunotherapy**
Introduction
Cristhina Kellen Fae is a notable inventor based in Mainz, Germany. With a focus on immunology, he has made significant strides in the field of pharmaceutical innovations. His work is particularly known for enhancing immune responses through advanced biotechnological methods.
Latest Patents
Cristhina holds a patent titled "FimH mutant, compositions therewith and use thereof." This invention involves polypeptides comprising a FimH lectin domain that features an amino acid mutation which induces a low affinity conformation for mannose. The patent further details pharmaceutical compositions that utilize these polypeptides and outlines methods to stimulate an immune response in patients through their administration.
Career Highlights
Cristhina is currently employed at Janssen Pharmaceuticals, Inc., where he continues to develop innovative medical solutions. His expertise in biochemistry and therapeutic design has positioned him as a leading figure in his domain, contributing to the advancement of treatment options for various medical conditions.
Collaborations
Throughout his career, Cristhina has collaborated with industry professionals such as Jan Grijpstra and Marleen Eveline Weerdenburg. These collaborations have fostered a dynamic environment for innovation and have led to advancements in the pharmaceutical sector.
Conclusion
Cristhina Kellen Fae’s contributions to the field of immunotherapy underline the importance of innovation in healthcare. With a strong patent portfolio and productive collaborations, he continues to influence the trajectory of medical treatments, showcasing the vital role of inventors in enhancing patient outcomes.